Authorization of Bamlanivimab with English-only Labels for Use in Relation to the COVID-19 Pandemic

Bamlanivimab was authorized for use in relation to the COVID-19 pandemic, in accordance with the Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19 . To provide earlier access to the product in the context of the global pandemic, Lilly will distribute one standard package worldwide with English-only labelling.

COVID - Product safety